Treatment of dyslipidemia in idiopathic inflammatory myositis: results of the International Myositis Assessment and Clinical Studies Group survey

Clinical Rheumatology, 05/11/2012

This survey suggests that statins are commonly used by physicians specializing in the treatment of patients with idiopathic inflammatory myositis (IIM) and that some myositis patients worsen with statin use and may improve on dechallenge. More research regarding the safety of lipid–lowering agents in patients with IIM is warranted.

Print Article Summary Cat 2 CME Report